English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/115755
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Dietary fatty acids and vitamin B3: an effective treatment strategy for the metabolic syndrome?

AuthorsMontserrat-de la Paz, Sergio ; López, Sergio ; Ortega, Almudena ; Varela, Lourdes; Abia, Rocío ; Muriana, Francisco J. G. ; Bermúdez, Beatriz
KeywordsOmega-3 PUFAs
Dietary oleic acid
Cardiovascular diseases
Metabolic syndrome
Issue Date2014
CitationThe Journal of Food & Nutritional Disorders 3: 6 (2014)
AbstractThe metabolic syndrome (MS) may be defined as the constellation of cardiovascular disease (CVD) risk factors that comprises obesity, type 2 diabetes, dyslipidemia, and hypertension. Recent evidences suggest that, primarily due to its high monounsaturated fatty acids (MUFAs) content, olive oil and omega-3 polyunsaturated fatty acids (PUFAs) could be useful as a dietary approach for MS management, with relevance in the postprandial state. Vitamin B3, as a major substrate for nicotinamide phosphoribosyltransferase (NAMPT), also constitutes a nutritional intervention strategy for the treatment of MS. NAMPT has been shown to exert activities of central importance to cellular energetics and innate immunity. Within the cell, NAMPT is the rate-limiting step in a salvage pathway of nicotinamide adenine dinucleotide (NAD+) biosynthesis. NAMPT has been shown to correlate with triglycerides in the fasting plasma, and a potential regulatory role for fatty acids on NAMPT expression has been proposed. Whether different dietary fatty acids, including olive oil as a source of MUFA, play a role in NAMPT excursions and in the NAMPT-dependent regulation of glucose and lipid metabolism and inflammation states remains to be solved. In general, the mechanisms that alter NAD+ metabolism probably include multiple processes, but the understandings of these mechanisms are currently very unclear and a considerable effort in this area is required before we know how changes in NAD+ metabolism influence physiology of glucose and lipid metabolism and how NAD+ metabolism might be manipulated for healing benefit by specific dietary fatty acids as a therapeutic treatment for MS.
Identifiersdoi: 10.4172/2324-9323.1000157
issn: 2324-9323
Appears in Collections:(IG) Artículos
Files in This Item:
File Description SizeFormat 
Postprint_JFND_2014_6.pdf827,33 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.